What's breaking now, across thousands of outlets.
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
(Ekaterina Demidova/Moment RF/Getty Images) Get moving to get things moving? Don't miss a story, subscribe here.
Russian state TV and other national state-controlled media have steered clear of the subject.
Russian state TV and other national state-controlled media have steered clear of the subject.
A new study led by University of Pittsburgh School of Medicine researchers finds that adults with attention-deficit/hyperactivity disorder (ADHD) face a significantly higher risk of developing…
Meadow EmmaLou Boes is proud of her scar and calls herself a "superhero heart warrior."
People were about 19 percentage points less likely to recommend life-sustaining treatment for a seriously ill patient with dementia than for a patient without dementia, even when an advance directive…
